BMRN
BioMarin Pharmaceutical Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #832
- Final score
- 30.96
- Years on list
- 6
↘ Down 183 since 2020
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- BMRN· BioMarin Pharmaceutical Inc.
- NBIX· Neurocrine Biosciences, Inc.
- JAZZ· Jazz Pharmaceuticals Plc
Figure 01 · Side-by-side summary
The headline numbers
NBIX
Neurocrine Biosciences, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #827
- Final score
- 31.40
- Years on list
- 6
↗ Climbed 2 since 2020
JAZZ
Jazz Pharmaceuticals PlcPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #842
- Final score
- 30.17
- Years on list
- 6
↘ Down 270 since 2020
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | BMRN | NBIX | JAZZ |
|---|---|---|---|
| Climate Change | 24.5 | 30.8 | 28.3 |
| Employee Relations | 38.6 | 36.5 | 37.5 |
| Environment | 26.8 | 31.9 | 18.8 |
| Stakeholders & Society | 25.1 | 22.4 | 41.1 |
| Human Rights | 28.8 | 16.4 | 18.3 |
| Governance | 36.3 | 44.2 | 31.1 |
| Performance Rating | 58.4 | 48.1 | 47.7 |